HIV Archive

  • A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...]

    New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1

    A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...]

    Continue Reading...

  • 
Moscow, October, 20 2008
Quantum and University of Pittsburgh announced a drug discovery collaboration in HIV sphere. Under the terms of agreement Quantum gets access to the target data from University [...]

    Quantum collaborates with University of Pittsburgh on HIV drug discovery.

    Moscow, October, 20 2008 Quantum and University of Pittsburgh announced a drug discovery collaboration in HIV sphere. Under the terms of agreement Quantum gets access to the target data from University [...]

    Continue Reading...

  •  Moscow, September, 28 2006
Quantum Pharmaceuticals and A.N. Belozersky Institute of Physico-Chemical Biology entered drug discovery collaboration aimed to discovery of novel small molecule inhibitors of HIV-1 integrase. HIV-1 integrase [...]

    HIV-1 integrase drug discovery collaboration

    Moscow, September, 28 2006 Quantum Pharmaceuticals and A.N. Belozersky Institute of Physico-Chemical Biology entered drug discovery collaboration aimed to discovery of novel small molecule inhibitors of HIV-1 integrase. HIV-1 integrase [...]

    Continue Reading...

Get Adobe Flash playerPlugin by wpburn.com wordpress themes